Oncology Pharma (ONPH) News Today

→ New crypto project uncovers 2,050% in 65 days (From InvestorPlace) (Ad)

$0.0005

0.00 (0.00%)

(As of 04/18/2024 ET)

Stock Analysis Chart Headlines Short Interest

Source

Source	Headline
	Nika Pharmaceuticals, Inc. (NKPH) Purchased the Technologies for Three Drugs in Tablet Form and One Dietary Supplement markets.businessinsider.com - April 17 at 8:53 PM
	Nuclear Medicine Is Big Pharma’s New Target in Cancer Race bloomberg.com - April 12 at 7:30 AM
	Onchilles Pharma Presents at AACR 2024 New Preclinical Data for N17350 and N17465 Demonstrating the Potential for Potent and Tumor-Selective Treatment businesswire.com - April 10 at 10:31 AM
	Boehringer Ingelheim Upbeat On China, Forms Cancer Drug Partnership msn.com - April 9 at 9:39 PM
	Kintara and TuHURA enter merger deal to advance oncology pipeline msn.com - April 4 at 9:00 PM
	Cancer biotech firm Alterome Therapeutics raises $132 mln in Goldman Sachs-led round msn.com - April 4 at 9:15 AM
	A new hope in immunotherapy against cancer msn.com - April 4 at 9:15 AM
	Regeneron's blood cancer therapy faces setback as FDA raises trial concerns msn.com - March 26 at 1:10 AM
	US FDA declines to approve Regeneron's blood cancer therapy msn.com - March 25 at 7:42 AM
	Clinical trial results show new Penn technology could be the key to fighting brain cancer bizjournals.com - March 21 at 4:00 AM
	AbilityPharma receives funds to advance pancreatic cancer trial msn.com - March 12 at 5:58 PM
	Iovance stock rises after FDA lifts clinical hold on lung cancer trial msn.com - March 4 at 8:23 AM
	Oncology Pharma Stock (OTC:ONPH) Dividends: History, Yield and Dates benzinga.com - February 27 at 10:00 AM
	Oncology Pharma Stock (OTC:ONPH), Analyst Ratings, Price Targets, Predictions benzinga.com - February 27 at 10:00 AM
	The doctor behind the next big thing in cancer treatment msn.com - February 20 at 11:34 PM
	The woman behind the next big thing in cancer treatment msn.com - February 20 at 1:32 PM
	Positive signs for new cancer treatment after trial on Oxford patients msn.com - February 19 at 2:12 AM
	UPDATE 3-US FDA grants accelerated approval for Iovance's skin cancer cell therapy msn.com - February 17 at 12:26 AM
	US FDA grants accelerated approval for Iovance's skin cancer cell therapy reuters.com - February 16 at 7:25 PM
	Cancer breakthrough as doctors celebrate new ‘wonder drug’ msn.com - February 15 at 1:37 PM
	Ono and Numab to develop antibody for cancer treatment msn.com - February 15 at 1:37 PM
	Boehringer and CBmed partner to develop cancer therapies msn.com - February 9 at 2:38 PM
	Accord Healthcare partners with ITN Business for World Cancer Day to explore how innovative approaches are helping shape the future of cancer care tmcnet.com - February 4 at 7:54 AM
	NeoPhore adds $12.2m in Series B extension for immuno-oncology pipeline msn.com - February 2 at 12:26 PM
	Kiromic BioPharma reports data from lung cancer therapy trial msn.com - January 30 at 7:28 PM
	Nanobiotix Gets $20M Milestone Payment for Head and Neck Cancer Study From Janssen marketwatch.com - January 29 at 6:15 PM
	HOOKIPA Pharma Provides Update on Business Priorities and Oncology Partnership Programs markets.businessinsider.com - January 29 at 9:10 AM
	U.S. IPO Weekly Recap: Biotech CG Oncology Pops 96% In A 7 IPO Week seekingalpha.com - January 27 at 3:40 AM
	Corbus Pharmaceuticals' Shares Triple Following Results From Phase 1 Cancer Study marketwatch.com - January 26 at 3:21 PM
	Corbus Pharma surges after early Phase 1 data for tumor candidate msn.com - January 26 at 3:21 PM
	CG Oncology IPO rockets 96% in sign of pent-up deal demand msn.com - January 25 at 6:22 PM
	CG Oncology Valued at $1.75 Billion in Strong Market Debut money.usnews.com - January 25 at 3:43 PM
	CG Oncology valued at $1.75 bln in strong market debut reuters.com - January 25 at 3:43 PM
	Kura Oncology Shares Rally After Oversubscription to Offering marketwatch.com - January 24 at 8:32 AM
	CG Oncology upsizes proposed IPO to $289M from $201M msn.com - January 23 at 6:46 PM
	CG Oncology upsizes proposed IPO to $201M from $100M msn.com - January 18 at 5:30 PM
	Q&A: Exploring the challenges behind oncology trials msn.com - January 12 at 10:33 AM
	Harvard, Dana-Farber create Cancer FactFinder website available in nine languages news.yahoo.com - January 8 at 8:34 AM
	CG Oncology files for proposed $100M IPO seekingalpha.com - January 6 at 8:41 AM
	CG Oncology Begins IPO Effort For Bladder Cancer Drug seekingalpha.com - January 5 at 2:47 PM
	Radionetics Oncology Raises $52.5 Million Series A to Advance First-in-Class Radiopharmaceutical Pipeline and Announces the Appointment of Industry Leader, Paul Grayson, as CEO businesswire.com - January 3 at 1:26 PM
	Cancer-treatment developer CG Oncology files for IPO msn.com - January 2 at 6:50 PM
	Iovance Biotherapeutics Up 17% After Wednesday Decline on Cancer Drug Study Clinical Hold marketwatch.com - December 28 at 1:41 PM
	Iovance falls after FDA clinical hold on mid-stage trial for lung cancer therapy msn.com - December 27 at 7:42 AM
	Insurance Approvals For Cancer Treatment: A New Model For Insurers And Providers forbes.com - December 22 at 12:35 PM
	Where Will Regeneron Pharmaceuticals Be in 1 Year? msn.com - December 22 at 12:35 PM
	Processa Pharmaceuticals Innovative Cancer Treatment Demonstrates Higher Efficacy at Lower Doses Over Capecitabine msn.com - December 19 at 8:17 PM
	Can community pharmacists reduce the incidence of skin cancer? msn.com - December 14 at 11:27 PM
	Rain Oncology to Be Bought By Pathos AI marketwatch.com - December 13 at 7:32 PM
	Bristol Myers to pay $800 million to Chinese drugmaker to develop cancer drug news.yahoo.com - December 12 at 6:43 PM

Get Oncology Pharma News Delivered to You Automatically

New crypto project uncovers 2,050% in 65 days (Ad)

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

Just click here to sign up and be among the first to get it.

ONPH Media Mentions By Week

ONPH Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ONPH
News Sentiment
▼
-0.04

0.53
▲
Average
Medical
News Sentiment

ONPH News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ONPH Articles
This Week
▼
2

2
▲
ONPH Articles
Average Week

Get Oncology Pharma News Delivered to You Automatically

Related Companies and Tools

Related Companies:

Headlines Tools:

This page (OTCMKTS:ONPH) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Oncology Pharma (ONPH) News Today

ONPH Media Mentions By Week

ONPH Media Sentiment

ONPH News Coverage

Related Companies and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info